| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Parker Geoffrey M. is a Chief Financial Officer at Allogene Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 8 buys and 2 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | PRGO Perrigo Co Plc | Director | Buy | 7,500 | $14.18 | $106,350.00 | +75.9% | +1.6% | - | |
| Oct 21, 2025 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 36,744 | $1.26 | $46,168.84 | -2.8% | +24.6% | - | |
| Aug 18, 2025 | PRGO Perrigo Co Plc | Director | Buy | 4,375 | $22.97 | $100,497.25 | +15.1% | -41.1% | - | |
| May 12, 2025 | PRGO Perrigo Co Plc | Director | Buy | 3,500 | $27.10 | $94,850.00 | +17.3% | -18.4% | - | |
| Feb 3, 2025 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 4,361 | $1.73 | $7,544.53 | -0.3% | -3.0% | +4.2% | |
| Jan 30, 2024 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Buy | 190 | $3.60 | $683.05 | - | -21.1% | -48.9% | |
| Jun 13, 2023 | PRGO Perrigo Co Plc | Director | Buy | 10,000 | $33.06 | $330,637.00 | +63.0% | +3.1% | -15.9% | |
| Mar 6, 2023 | PRGO Perrigo Co Plc | Director | Buy | 5,000 | $38.05 | $190,270.00 | +46.0% | -10.6% | -26.2% | |
| Dec 16, 2021 | PRGO Perrigo Co Plc | Director | Buy | 5,000 | $36.85 | $184,270.00 | +85.0% | +4.0% | -12.3% | |
| Mar 17, 2021 | PRGO Perrigo Co Plc | Director | Buy | 2,500 | $41.29 | $103,217.75 | +1,667% | +15.2% | -4.7% |